Ilevro

Chronic Pain, Inflammation, Cataract Surgery

Treatment

5 FDA approvals

20 Active Studies for Ilevro

What is Ilevro

Nepafenac

The Generic name of this drug

Treatment Summary

Nepafenac is a medication used to treat pain and inflammation after cataract surgery. It is an NSAID (non-steroidal anti-inflammatory drug) that comes in the form of a prescription eye drop.

Nevanac

is the brand name

image of different drug pills on a surface

Ilevro Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Nevanac

Nepafenac

2005

5

Approved as Treatment by the FDA

Nepafenac, also known as Nevanac, is approved by the FDA for 5 uses like Pain and Inflammation .

Pain

Helps manage Pain

Inflammation

Helps manage Inflammation

Chronic Pain

Helps manage Pain

Cataract Surgery

Helps manage Cataract Surgery

Inflammation

Helps manage Inflammation

Effectiveness

How Ilevro Affects Patients

When Nepafenac ophthalmic suspension is taken three times a day, measurable amounts of Nepafenac and Amfenac are present in the blood after two and three hours respectively. On average, the maximum amount of Nepafenac and Amfenac in the blood was 0.310 and 0.422 nanograms per milliliter, respectively.

How Ilevro works in the body

Nepafenac is a drug that is changed in the body to amfenac, a type of pain reliever. Amfenac works by blocking the activity of two enzymes, COX1 and COX2. This helps reduce inflammation and pain.

When to interrupt dosage

The recommended measure of Ilevro is contingent upon the diagnosed condition, for example Inflammation, Cataract Surgery and Chronic Pain. The quantity of dosage fluctuates, according to the administration mode (e.g. Suspension / drops or Ophthalmic) featured in the table beneath.

Condition

Dosage

Administration

Chronic Pain

, 1.0 mg/mL, 3.0 mg/mL, 0.3 %, 0.1 %

Suspension / drops - Ophthalmic, , Ophthalmic, Suspension / drops, Suspension, Suspension - Ophthalmic

Cataract Surgery

, 1.0 mg/mL, 3.0 mg/mL, 0.3 %, 0.1 %

Suspension / drops - Ophthalmic, , Ophthalmic, Suspension / drops, Suspension, Suspension - Ophthalmic

Inflammation

, 1.0 mg/mL, 3.0 mg/mL, 0.3 %, 0.1 %

Suspension / drops - Ophthalmic, , Ophthalmic, Suspension / drops, Suspension, Suspension - Ophthalmic

Warnings

Ilevro Contraindications

Condition

Risk Level

Notes

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Ilevro.

Common Ilevro Drug Interactions

Drug Name

Risk Level

Description

Valproic acid

Minor

The protein binding of Valproic acid can be decreased when combined with Nepafenac.

Acemetacin

Moderate

The risk or severity of adverse effects can be increased when Nepafenac is combined with Acemetacin.

Acetylsalicylic acid

Moderate

The therapeutic efficacy of Acetylsalicylic acid can be decreased when used in combination with Nepafenac.

Alclofenac

Moderate

The risk or severity of adverse effects can be increased when Nepafenac is combined with Alclofenac.

Alminoprofen

Moderate

The risk or severity of adverse effects can be increased when Nepafenac is combined with Alminoprofen.

Ilevro Toxicity & Overdose Risk

Applying non-steroidal anti-inflammatory drugs to the eyes can lead to increased bleeding in the eye area during eye surgery.

image of a doctor in a lab doing drug, clinical research

Ilevro Novel Uses: Which Conditions Have a Clinical Trial Featuring Ilevro?

357 active studies are currently being undertaken to assess the potential of Ilevro in alleviating Inflammation, Chronic Pain and assisting with Cataract Surgery.

Condition

Clinical Trials

Trial Phases

Inflammation

58 Actively Recruiting

Not Applicable, Early Phase 1, Phase 1, Phase 2, Phase 3, Phase 4

Chronic Pain

130 Actively Recruiting

Not Applicable, Phase 4, Phase 2, Phase 3, Early Phase 1, Phase 1

Cataract Surgery

3 Actively Recruiting

Not Applicable, Phase 4

Ilevro Reviews: What are patients saying about Ilevro?

5

Patient Review

8/28/2016

Ilevro for Inflammation of the Eye Following Surgery

I took this treatment once a day for 7 days, and then due to irritation from the antibiotic, I dropped down to 2 drops a day for 7 days. I had a sample bottle which only lasted me until day 11. From my experience, I think that one bottle would last if you're only taking 1 drop a day for two weeks. However, since I ran out before finishing the full 14 days, I had to get a prescription for the other eye. This medication is pricey, but my insurance did give me a special authorization and covered it.

5

Patient Review

6/17/2017

Ilevro for Inflammation of the Eye Following Surgery

Helped to relieve pain after a failed glaucoma surgery. Not as easy to apply as OTC eyedrops, but this was much more effective and long-lasting.

4

Patient Review

10/29/2013

Ilevro for Inflammation of the Eye Following Surgery

3.3

Patient Review

1/1/2014

Ilevro for Inflammation of the Eye Following Surgery

The bottle was very small and expensive. The design of the bottle tip was such that the medication would drip down the side of the bottle after application, wasting a small amount each time. Other eye drops I used had better tip design.

3

Patient Review

3/22/2019

Ilevro for Inflammation of the Eye Following Surgery

I used this once in the morning and evening for cataracts/LASIK and it did the job well. The only side effect was temporary blurring, but that was manageable. The bottle is really difficult to use though.

2

Patient Review

3/26/2016

Ilevro for Postoperative Pain in Eye

The bottle is rigid, and the fluid inside is very viscous. It barely lasted me three weeks. Since it's not a covered medication, unless you're careful with your usage, you'll end up having to pay for another bottle before you're supposed to.

1.7

Patient Review

8/8/2014

Ilevro for Postoperative Pain in Eye

The design of this dropper is very poor. There is only enough medicine for 25 days, so you have to be careful when using it.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about ilevro

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the drug Ilevro used for?

"This medication is used to relieve eye pain, irritation, and redness following cataract eye surgery. Nepafenac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs work by reducing swelling and inflammation."

Answered by AI

What are the side effects of Ilevro eye drops?

"The sensation of a foreign body in the eye, increased intraocular pressure, a sticky sensation in the eye, eye or eyelid swelling, dry eye, crusting of the eyelids, eye discomfort or pain, and itchy eyes are all symptoms of conjunctivitis."

Answered by AI

What kind of drug is Ilevro?

"Ilevro is a non-steroidal anti-inflammatory drug (NSAID) that lessens pain and swelling in the eye due to surgery by stopping your body from making chemicals that cause inflammation."

Answered by AI

Is Ilevro a generic drug?

"At the moment, there is no cheaper alternative to Ilevro that has the same therapeutic effect in the United States. Be aware that there are many illegal online pharmacies that might try to sell you a generic version of Ilevro. These medicines could be fake and potentially dangerous."

Answered by AI

Clinical Trials for Ilevro

Image of Montana State University in Bozeman, United States.

Haskap Berries for Exercise Performance Recovery

18 - 35
All Sexes
Bozeman, MT

The purpose of this clinical trial is to determine how certain food items affect oxidative stress, inflammation, and performance recovery from exercise induced muscle damage in a resistance trained population. The main questions The investigators aim to answer are the following: * Do Haskaps speed the recovery of oxidative stress and inflammation markers after an intense lower body workout in resistance trained adults? * Do Haskaps speed the recovery of performance measures after an intense lower body workout in resistance trained adults? * The data collected in this investigation may also be used to ask additional questions not yet identified. For example, the investigators may use the stored samples to evaluate how the blood metabolites of participants differ before and after intense exercise. These additional questions are called secondary analyses. Please note that no genetic analysis will be conducted and racial and ethnic differences among participants will not be used in any secondary analyses. Researches will compare Haskap juice to a color, flavor and carbohydrate matched placebo to see if Haskaps speed recovery in inflammation, oxidative stress and performance. * Participants will be asked to drink either Haskap juice or placebo and follow a low polyphenolic diet * Participants will perform an intense resistance workout * Participants will have their blood drawn before and after the workout * Performance will be analyzed at 24, 48 and 72 hours after the workout

Recruiting
Paid Trial

Montana State University

Mary P Miles

Image of AltaSciences, Inc in Cypress, United States.

SBS-147 Safety Study

18 - 55
All Sexes
Cypress, CA

This study is part of the HEAL Initiative supported by the NIH. The purpose of this study is to learn how safe the study drug, SBS-147, is and how people's bodies respond to and process it. Researchers will also look for any side effects that may occur when taking SBS-147. Some participants will receive SBS-147, and others will receive a placebo, which looks the same but does not contain any medicine. This helps researchers fairly compare results. The study includes two parts: Single-Dose Group, where Participants receive SBS-147 or placebo one time. Multiple-Dose Group, where Participants receive SBS-147 or placebo once or twice daily for 7 days.

Phase 1
Waitlist Available

AltaSciences, Inc

Jeff Reich, MD

Sparian Biosciences, Inc

Have you considered Ilevro clinical trials?

We made a collection of clinical trials featuring Ilevro, we think they might fit your search criteria.
Go to Trials
Image of University of New Brunswick in Fredericton, Canada.

Mediterranean Diet for Toddler Health

24 - 36
All Sexes
Fredericton, Canada

Toddlerhood (ages 2-3) is a critical window when the gut microbiome is still developing and eating habits are being established. Yet, many Canadian toddlers eat diets high in sugar and salt, which may affect long-term health. This study will test whether a MED diet can improve dietary inflammation, gut health, and body composition in toddlers and whether a tailored nutrition education program for parents can help families maintain healthy eating patterns. In this study, toddlers will be randomly assigned to a 3-week MED diet or their usual diet. Families in the MED diet group will receive free meal boxes for the 3 weeks, plus guidance from a nutrition researcher through a structured education program. The standard diet group will continue their regular diet with general nutrition advice. Researchers will collect dietary information, body composition assessments, and stool samples to measure gut microbiome composition and metabolites. This first study of a controlled diet intervention in toddlers, combining behavioral support, high-quality food provision, and advanced gut microbiome analysis, will help understand how early diet shapes lifelong eating habits and health, guiding public health strategies and precision nutrition approaches to prevent chronic disease from early life.

Waitlist Available
Has No Placebo

University of New Brunswick

Dr. Maryam Kebbe, PhD, CLC

Have you considered Ilevro clinical trials?

We made a collection of clinical trials featuring Ilevro, we think they might fit your search criteria.
Go to Trials
Image of University of California, San Francisco in San Francisco, United States.

Vision Centers for Eye Care

Any Age
All Sexes
San Francisco, CA

The goal of this clinical trial is to evaluate the effect of vision centers on access to eye care and eye health outcomes in South Asia. The main questions it aims to answer are: 1. Do vision centers increase visits to eyecare centers? 2. Do vision centers increase spectacle ownership and wearing? 3. Do vision centers improve visual acuity of the population? Researchers will compare outcomes in communities randomized to have a vision center is established with communities randomized to delay establishment of a vision center. Outcomes will be assessed through population-based surveys at baseline and after two years as well as through hospital records collected throughout the study period.

Waitlist Available
Has No Placebo

University of California, San Francisco

Kieran O'Brien, PhD, MPH

Have you considered Ilevro clinical trials?

We made a collection of clinical trials featuring Ilevro, we think they might fit your search criteria.
Go to Trials